

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.94485405 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.15164991 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.15164991 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.77141458 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.61823049 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.49096560 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.15616229 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 5.07161666 |
| 9 | negative T cell selection (GO:0043383) | 5.05228280 |
| 10 | interferon-gamma production (GO:0032609) | 5.02181674 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.97752472 |
| 12 | negative thymic T cell selection (GO:0045060) | 4.89707130 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.73378136 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.73378136 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.62568404 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.62568404 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 4.62568404 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 4.62568404 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 4.62568404 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.62568404 |
| 21 | regulation of B cell differentiation (GO:0045577) | 4.62130327 |
| 22 | positive thymic T cell selection (GO:0045059) | 4.57928723 |
| 23 | response to interleukin-15 (GO:0070672) | 4.50081070 |
| 24 | detection of other organism (GO:0098543) | 4.45248205 |
| 25 | detection of bacterium (GO:0016045) | 4.44329733 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 4.42869096 |
| 27 | B cell receptor signaling pathway (GO:0050853) | 4.37144317 |
| 28 | ribosomal small subunit assembly (GO:0000028) | 4.31450520 |
| 29 | positive regulation of B cell differentiation (GO:0045579) | 4.28526799 |
| 30 | cellular response to interleukin-15 (GO:0071350) | 4.23863546 |
| 31 | leukocyte aggregation (GO:0070486) | 4.19532902 |
| 32 | mast cell activation (GO:0045576) | 4.17705643 |
| 33 | thymic T cell selection (GO:0045061) | 4.06891076 |
| 34 | positive T cell selection (GO:0043368) | 4.02409416 |
| 35 | T cell selection (GO:0045058) | 3.95264153 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.91930112 |
| 37 | response to peptidoglycan (GO:0032494) | 3.91382411 |
| 38 | T cell migration (GO:0072678) | 3.91119045 |
| 39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.90700945 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 3.87000779 |
| 41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.85416995 |
| 42 | T cell homeostasis (GO:0043029) | 3.74086017 |
| 43 | regulation of T cell tolerance induction (GO:0002664) | 3.73692191 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 3.71979440 |
| 45 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.69832452 |
| 46 | negative regulation of T cell mediated immunity (GO:0002710) | 3.63911692 |
| 47 | mast cell degranulation (GO:0043303) | 3.63248774 |
| 48 | mast cell activation involved in immune response (GO:0002279) | 3.63248774 |
| 49 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.62180911 |
| 50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.62082383 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.62021317 |
| 52 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.61529609 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.60185752 |
| 54 | negative regulation of phagocytosis (GO:0050765) | 3.58002494 |
| 55 | T cell receptor signaling pathway (GO:0050852) | 3.56539082 |
| 56 | respiratory burst (GO:0045730) | 3.55096161 |
| 57 | positive regulation of tolerance induction (GO:0002645) | 3.53804999 |
| 58 | neutrophil activation (GO:0042119) | 3.52708926 |
| 59 | detection of external biotic stimulus (GO:0098581) | 3.49666822 |
| 60 | response to muramyl dipeptide (GO:0032495) | 3.49508100 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 3.45316248 |
| 62 | T cell costimulation (GO:0031295) | 3.45283657 |
| 63 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.42174167 |
| 64 | lymphocyte costimulation (GO:0031294) | 3.41685439 |
| 65 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.41099751 |
| 66 | response to host immune response (GO:0052572) | 3.41099751 |
| 67 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.37654909 |
| 68 | regulation of mast cell degranulation (GO:0043304) | 3.35871834 |
| 69 | regulation of antigen processing and presentation (GO:0002577) | 3.25914247 |
| 70 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.24697263 |
| 71 | granulocyte activation (GO:0036230) | 3.24670861 |
| 72 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.23688257 |
| 73 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.21472064 |
| 74 | regulation of tolerance induction (GO:0002643) | 3.21376128 |
| 75 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.20051486 |
| 76 | immunoglobulin mediated immune response (GO:0016064) | 3.17586808 |
| 77 | viral transcription (GO:0019083) | 3.17559257 |
| 78 | positive regulation of antigen processing and presentation (GO:0002579) | 3.16904211 |
| 79 | myeloid dendritic cell activation (GO:0001773) | 3.15316419 |
| 80 | lymphocyte homeostasis (GO:0002260) | 3.14593983 |
| 81 | leukocyte degranulation (GO:0043299) | 3.14199766 |
| 82 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.13522436 |
| 83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.11940562 |
| 84 | response to host (GO:0075136) | 3.11940562 |
| 85 | response to host defenses (GO:0052200) | 3.11940562 |
| 86 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.10818107 |
| 87 | megakaryocyte development (GO:0035855) | 3.09477949 |
| 88 | tolerance induction (GO:0002507) | 3.09149591 |
| 89 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.08442913 |
| 90 | negative regulation of innate immune response (GO:0045824) | 3.06387416 |
| 91 | cellular response to zinc ion (GO:0071294) | 3.05999447 |
| 92 | detection of biotic stimulus (GO:0009595) | 3.05909410 |
| 93 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.05709219 |
| 94 | activated T cell proliferation (GO:0050798) | 3.04423647 |
| 95 | positive regulation of mast cell activation (GO:0033005) | 3.04365848 |
| 96 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.03503609 |
| 97 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.02332736 |
| 98 | translational termination (GO:0006415) | 3.01678837 |
| 99 | germinal center formation (GO:0002467) | 2.98545281 |
| 100 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.97977051 |
| 101 | regulation of regulatory T cell differentiation (GO:0045589) | 2.96596097 |
| 102 | lymph node development (GO:0048535) | 2.96546799 |
| 103 | positive regulation of granulocyte differentiation (GO:0030854) | 2.96306953 |
| 104 | regulation of mast cell activation (GO:0033003) | 2.95727839 |
| 105 | positive regulation of isotype switching (GO:0045830) | 2.93139568 |
| 106 | B cell homeostasis (GO:0001782) | 2.92536868 |
| 107 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.92377948 |
| 108 | natural killer cell activation (GO:0030101) | 2.92056798 |
| 109 | mature B cell differentiation (GO:0002335) | 2.91413530 |
| 110 | leukocyte homeostasis (GO:0001776) | 2.88730384 |
| 111 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.88483157 |
| 112 | response to type I interferon (GO:0034340) | 2.87934581 |
| 113 | mature B cell differentiation involved in immune response (GO:0002313) | 2.86114232 |
| 114 | T cell differentiation (GO:0030217) | 2.85647500 |
| 115 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.85546087 |
| 116 | cellular response to type I interferon (GO:0071357) | 2.85055022 |
| 117 | type I interferon signaling pathway (GO:0060337) | 2.85055022 |
| 118 | leukocyte cell-cell adhesion (GO:0007159) | 2.84654540 |
| 119 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.83521108 |
| 120 | regulation of response to interferon-gamma (GO:0060330) | 2.83432001 |
| 121 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.83303173 |
| 122 | cellular extravasation (GO:0045123) | 2.82839345 |
| 123 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.81050889 |
| 124 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.80162678 |
| 125 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.80162678 |
| 126 | B cell mediated immunity (GO:0019724) | 2.80013438 |
| 127 | NIK/NF-kappaB signaling (GO:0038061) | 2.78317184 |
| 128 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.77741372 |
| 129 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.75520655 |
| 130 | response to protozoan (GO:0001562) | 2.73480742 |
| 131 | * positive regulation of interleukin-2 production (GO:0032743) | 2.72644045 |
| 132 | natural killer cell differentiation (GO:0001779) | 2.72467070 |
| 133 | positive regulation of lamellipodium assembly (GO:0010592) | 2.71147781 |
| 134 | myeloid dendritic cell differentiation (GO:0043011) | 2.68318906 |
| 135 | ribosomal small subunit biogenesis (GO:0042274) | 2.67923785 |
| 136 | defense response to protozoan (GO:0042832) | 2.67704983 |
| 137 | T cell proliferation (GO:0042098) | 2.67512017 |
| 138 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.66980849 |
| 139 | Peyers patch development (GO:0048541) | 2.66980849 |
| 140 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.66913484 |
| 141 | T cell activation (GO:0042110) | 2.66430177 |
| 142 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.65450948 |
| 143 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.65450948 |
| 144 | translational elongation (GO:0006414) | 2.64606598 |
| 145 | cellular response to interferon-beta (GO:0035458) | 2.64516213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.52120739 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.22108064 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.16704011 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.95052030 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.61206634 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.36919972 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.31553888 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.02219514 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.96102702 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.81206286 |
| 11 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.75215821 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.75090583 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.59666382 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.55842720 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.55243321 |
| 16 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.49366075 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.46808569 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.46044052 |
| 19 | * MAF_26560356_Chip-Seq_TH1_Human | 2.38987926 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34224288 |
| 21 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.31626737 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.31575743 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.30529204 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.30173937 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.27141018 |
| 26 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.25034074 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.22260220 |
| 28 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22207161 |
| 29 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.14861401 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.12443806 |
| 31 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05988364 |
| 32 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.04162103 |
| 33 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01225263 |
| 34 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.00159926 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.99645801 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.96536531 |
| 37 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94706525 |
| 38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.89536536 |
| 39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.88010151 |
| 40 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.84635175 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82211581 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81674924 |
| 43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.77916465 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76432373 |
| 45 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76011802 |
| 46 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72286685 |
| 47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.69435850 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68149720 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64188569 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.63522958 |
| 51 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.58145822 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.56314681 |
| 53 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.56308601 |
| 54 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.55956446 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.53786110 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50786314 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46560433 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46225549 |
| 59 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.44881925 |
| 60 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43305049 |
| 61 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.42647559 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.42547203 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38948833 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37850707 |
| 65 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.35977761 |
| 66 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.33845691 |
| 67 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.30562379 |
| 68 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.30085405 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26961317 |
| 70 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26208811 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25505799 |
| 72 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25402727 |
| 73 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.22966248 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21804456 |
| 75 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20662178 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15984684 |
| 77 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13521245 |
| 78 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.13133401 |
| 79 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12567527 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12480858 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12194259 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12173391 |
| 83 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.10944985 |
| 84 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.10351041 |
| 85 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.09435706 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08968429 |
| 87 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07768197 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06729841 |
| 89 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06229738 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06181163 |
| 91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05490060 |
| 92 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.05458148 |
| 93 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.05038041 |
| 94 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04099096 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03775731 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03008072 |
| 97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02989867 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02852380 |
| 99 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.02066952 |
| 100 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.01197313 |
| 101 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.00323761 |
| 102 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98266524 |
| 103 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97530732 |
| 104 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96152069 |
| 105 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95764223 |
| 106 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95307946 |
| 107 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92750368 |
| 108 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92460983 |
| 109 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92431058 |
| 110 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.91724263 |
| 111 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91501372 |
| 112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91404454 |
| 113 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91237832 |
| 114 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90049254 |
| 115 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.89073060 |
| 116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88498176 |
| 117 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86728860 |
| 118 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.86272423 |
| 119 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85854030 |
| 120 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.85750261 |
| 121 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.85280074 |
| 122 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84809506 |
| 123 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84765161 |
| 124 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.84473057 |
| 125 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.83184630 |
| 126 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82008225 |
| 127 | P300_27268052_Chip-Seq_Bcells_Human | 0.82007406 |
| 128 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.81089557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.20680660 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.96408868 |
| 3 | * MP0005671_abnormal_response_to | 3.74416798 |
| 4 | MP0000685_abnormal_immune_system | 3.42514806 |
| 5 | * MP0001800_abnormal_humoral_immune | 3.34725570 |
| 6 | MP0002396_abnormal_hematopoietic_system | 3.33459608 |
| 7 | MP0001790_abnormal_immune_system | 3.00227327 |
| 8 | MP0005387_immune_system_phenotype | 3.00227327 |
| 9 | MP0009785_altered_susceptibility_to | 2.91150675 |
| 10 | * MP0002398_abnormal_bone_marrow | 2.89350247 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.88622582 |
| 12 | * MP0002420_abnormal_adaptive_immunity | 2.86585644 |
| 13 | * MP0001819_abnormal_immune_cell | 2.82298721 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.80944042 |
| 15 | * MP0002723_abnormal_immune_serum | 2.80592656 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.71500593 |
| 17 | MP0003436_decreased_susceptibility_to | 2.66290894 |
| 18 | MP0005025_abnormal_response_to | 2.57560287 |
| 19 | * MP0000716_abnormal_immune_system | 2.51305114 |
| 20 | * MP0000689_abnormal_spleen_morphology | 2.38700168 |
| 21 | * MP0002722_abnormal_immune_system | 2.38214651 |
| 22 | MP0000703_abnormal_thymus_morphology | 2.30294218 |
| 23 | MP0002006_tumorigenesis | 2.29952543 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.27160104 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 2.21264532 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.21068305 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.18709259 |
| 28 | MP0002405_respiratory_system_inflammati | 2.18284799 |
| 29 | * MP0002429_abnormal_blood_cell | 2.16041113 |
| 30 | MP0002419_abnormal_innate_immunity | 2.15147984 |
| 31 | MP0001873_stomach_inflammation | 2.09709523 |
| 32 | MP0010155_abnormal_intestine_physiology | 2.00149625 |
| 33 | MP0006082_CNS_inflammation | 1.95995746 |
| 34 | MP0003303_peritoneal_inflammation | 1.83601627 |
| 35 | MP0005174_abnormal_tail_pigmentation | 1.78052938 |
| 36 | MP0003866_abnormal_defecation | 1.76145605 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.72953446 |
| 38 | MP0001853_heart_inflammation | 1.69154834 |
| 39 | * MP0001845_abnormal_inflammatory_respons | 1.69016342 |
| 40 | MP0000490_abnormal_crypts_of | 1.66161090 |
| 41 | MP0004947_skin_inflammation | 1.63601837 |
| 42 | MP0005075_abnormal_melanosome_morpholog | 1.62955385 |
| 43 | MP0003724_increased_susceptibility_to | 1.61764951 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.57221503 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.57221503 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.52378393 |
| 47 | MP0005310_abnormal_salivary_gland | 1.44473584 |
| 48 | MP0002933_joint_inflammation | 1.38423961 |
| 49 | MP0010094_abnormal_chromosome_stability | 1.37835444 |
| 50 | MP0008057_abnormal_DNA_replication | 1.36152287 |
| 51 | MP0002019_abnormal_tumor_incidence | 1.31693486 |
| 52 | MP0008260_abnormal_autophagy | 1.24324668 |
| 53 | MP0003828_pulmonary_edema | 1.24193860 |
| 54 | MP0008469_abnormal_protein_level | 1.22748647 |
| 55 | MP0000858_altered_metastatic_potential | 1.20265839 |
| 56 | MP0003077_abnormal_cell_cycle | 1.20037052 |
| 57 | MP0009278_abnormal_bone_marrow | 1.18979889 |
| 58 | MP0005451_abnormal_body_composition | 1.14938728 |
| 59 | MP0004510_myositis | 1.14891456 |
| 60 | MP0002009_preneoplasia | 1.12414193 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.10204199 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.10022845 |
| 63 | MP0002132_abnormal_respiratory_system | 1.09587767 |
| 64 | MP0003693_abnormal_embryo_hatching | 1.08722443 |
| 65 | MP0002095_abnormal_skin_pigmentation | 1.05703529 |
| 66 | MP0004957_abnormal_blastocyst_morpholog | 1.04739275 |
| 67 | MP0010352_gastrointestinal_tract_polyps | 1.02704207 |
| 68 | MP0003448_altered_tumor_morphology | 1.01917403 |
| 69 | MP0000015_abnormal_ear_pigmentation | 0.97084323 |
| 70 | MP0008058_abnormal_DNA_repair | 0.96930740 |
| 71 | MP0003075_altered_response_to | 0.96346317 |
| 72 | MP0008007_abnormal_cellular_replicative | 0.94695765 |
| 73 | MP0003183_abnormal_peptide_metabolism | 0.91532213 |
| 74 | MP0003172_abnormal_lysosome_physiology | 0.91189668 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 0.90387300 |
| 76 | MP0006054_spinal_hemorrhage | 0.90196665 |
| 77 | MP0004883_abnormal_blood_vessel | 0.88670988 |
| 78 | MP0003111_abnormal_nucleus_morphology | 0.81799112 |
| 79 | MP0000313_abnormal_cell_death | 0.79159889 |
| 80 | MP0001851_eye_inflammation | 0.78044428 |
| 81 | MP0003045_fibrosis | 0.75501555 |
| 82 | MP0000604_amyloidosis | 0.75022184 |
| 83 | MP0003690_abnormal_glial_cell | 0.72236248 |
| 84 | MP0009763_increased_sensitivity_to | 0.71614811 |
| 85 | MP0000343_altered_response_to | 0.71426857 |
| 86 | MP0005390_skeleton_phenotype | 0.70306254 |
| 87 | MP0003191_abnormal_cellular_cholesterol | 0.68032147 |
| 88 | MP0009764_decreased_sensitivity_to | 0.67825174 |
| 89 | MP0004381_abnormal_hair_follicle | 0.64224615 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.64112189 |
| 91 | MP0009840_abnormal_foam_cell | 0.63858322 |
| 92 | MP0000477_abnormal_intestine_morphology | 0.61282269 |
| 93 | MP0005058_abnormal_lysosome_morphology | 0.60528064 |
| 94 | MP0003943_abnormal_hepatobiliary_system | 0.60513315 |
| 95 | MP0001986_abnormal_taste_sensitivity | 0.59824150 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 0.59752923 |
| 97 | MP0005023_abnormal_wound_healing | 0.58557851 |
| 98 | MP0001663_abnormal_digestive_system | 0.58337592 |
| 99 | MP0008874_decreased_physiological_sensi | 0.57286373 |
| 100 | MP0010307_abnormal_tumor_latency | 0.56866120 |
| 101 | MP0005164_abnormal_response_to | 0.56847713 |
| 102 | MP0002693_abnormal_pancreas_physiology | 0.55624069 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.55009177 |
| 104 | MP0000249_abnormal_blood_vessel | 0.54640060 |
| 105 | MP0008961_abnormal_basal_metabolism | 0.53710888 |
| 106 | MP0000371_diluted_coat_color | 0.53477619 |
| 107 | MP0000350_abnormal_cell_proliferation | 0.53257324 |
| 108 | MP0008004_abnormal_stomach_pH | 0.52954516 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.52586884 |
| 110 | MP0008873_increased_physiological_sensi | 0.51987075 |
| 111 | MP0002075_abnormal_coat/hair_pigmentati | 0.48010569 |
| 112 | MP0003656_abnormal_erythrocyte_physiolo | 0.47492953 |
| 113 | MP0000598_abnormal_liver_morphology | 0.46792498 |
| 114 | MP0003795_abnormal_bone_structure | 0.46643227 |
| 115 | MP0003252_abnormal_bile_duct | 0.43317138 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.42763346 |
| 117 | MP0000609_abnormal_liver_physiology | 0.42538835 |
| 118 | MP0005166_decreased_susceptibility_to | 0.42470032 |
| 119 | MP0002083_premature_death | 0.41239456 |
| 120 | MP0003091_abnormal_cell_migration | 0.40267563 |
| 121 | MP0005381_digestive/alimentary_phenotyp | 0.38645143 |
| 122 | MP0009642_abnormal_blood_homeostasis | 0.35720280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.24599894 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.00108018 |
| 3 | Recurrent bronchitis (HP:0002837) | 4.91923241 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.86763981 |
| 5 | IgM deficiency (HP:0002850) | 4.85219836 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 4.70262120 |
| 7 | Recurrent viral infections (HP:0004429) | 4.66073781 |
| 8 | Chronic otitis media (HP:0000389) | 4.54713895 |
| 9 | Myositis (HP:0100614) | 4.41238338 |
| 10 | Agammaglobulinemia (HP:0004432) | 4.38563593 |
| 11 | Abnormality of T cells (HP:0002843) | 4.36665987 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.26816729 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.03068268 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.00956848 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.93748939 |
| 16 | Combined immunodeficiency (HP:0005387) | 3.86554597 |
| 17 | B lymphocytopenia (HP:0010976) | 3.82755594 |
| 18 | Abnormality of B cell number (HP:0010975) | 3.82755594 |
| 19 | Severe combined immunodeficiency (HP:0004430) | 3.82171566 |
| 20 | Thrombocytosis (HP:0001894) | 3.82103507 |
| 21 | IgG deficiency (HP:0004315) | 3.79990412 |
| 22 | Thyroiditis (HP:0100646) | 3.79914182 |
| 23 | Meningitis (HP:0001287) | 3.75707482 |
| 24 | Nasal polyposis (HP:0100582) | 3.72146540 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.68229283 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.68229283 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 3.53967019 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 3.45878839 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.45519688 |
| 30 | Lymphopenia (HP:0001888) | 3.40947491 |
| 31 | Cellulitis (HP:0100658) | 3.39716273 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 3.36780820 |
| 33 | Petechiae (HP:0000967) | 3.29649825 |
| 34 | Increased IgM level (HP:0003496) | 3.29531446 |
| 35 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.28648874 |
| 36 | Abnormality of the nasal mucosa (HP:0000433) | 3.27798340 |
| 37 | Gastrointestinal inflammation (HP:0004386) | 3.26457550 |
| 38 | Inflammation of the large intestine (HP:0002037) | 3.24501505 |
| 39 | Urticaria (HP:0001025) | 3.19653759 |
| 40 | Recurrent sinusitis (HP:0011108) | 3.10911560 |
| 41 | Hypoplasia of the thymus (HP:0000778) | 3.07942927 |
| 42 | Orchitis (HP:0100796) | 3.07813300 |
| 43 | Abnormality of eosinophils (HP:0001879) | 3.04549740 |
| 44 | Recurrent skin infections (HP:0001581) | 3.03424435 |
| 45 | Vasculitis (HP:0002633) | 3.03240086 |
| 46 | Eosinophilia (HP:0001880) | 3.00441697 |
| 47 | Retrobulbar optic neuritis (HP:0100654) | 2.99195816 |
| 48 | Optic neuritis (HP:0100653) | 2.99195816 |
| 49 | Prolonged bleeding time (HP:0003010) | 2.91529214 |
| 50 | Pustule (HP:0200039) | 2.89855009 |
| 51 | Colitis (HP:0002583) | 2.88038801 |
| 52 | Leukocytosis (HP:0001974) | 2.87882204 |
| 53 | Gastrointestinal stroma tumor (HP:0100723) | 2.87025898 |
| 54 | Gingivitis (HP:0000230) | 2.85634688 |
| 55 | Encephalitis (HP:0002383) | 2.85442326 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.85342319 |
| 57 | Granulocytopenia (HP:0001913) | 2.82765668 |
| 58 | Lymphoma (HP:0002665) | 2.76636786 |
| 59 | Abnormal number of erythroid precursors (HP:0012131) | 2.76418233 |
| 60 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.76333231 |
| 61 | Bronchitis (HP:0012387) | 2.74924746 |
| 62 | Abnormality of the fingertips (HP:0001211) | 2.74001894 |
| 63 | Chronic diarrhea (HP:0002028) | 2.73503348 |
| 64 | Papilloma (HP:0012740) | 2.73415168 |
| 65 | Verrucae (HP:0200043) | 2.73415168 |
| 66 | Stomatitis (HP:0010280) | 2.73194374 |
| 67 | Chronic sinusitis (HP:0011109) | 2.70737118 |
| 68 | Obstructive lung disease (HP:0006536) | 2.66961630 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.66961630 |
| 70 | IgA deficiency (HP:0002720) | 2.65497806 |
| 71 | Spontaneous hematomas (HP:0007420) | 2.57633417 |
| 72 | Epistaxis (HP:0000421) | 2.52332571 |
| 73 | Autoimmune thrombocytopenia (HP:0001973) | 2.49171989 |
| 74 | Pulmonary embolism (HP:0002204) | 2.41365060 |
| 75 | Pulmonary infiltrates (HP:0002113) | 2.38825755 |
| 76 | Recurrent pneumonia (HP:0006532) | 2.37656781 |
| 77 | Aplastic anemia (HP:0001915) | 2.32475452 |
| 78 | Abnormality of the pleura (HP:0002103) | 2.30670860 |
| 79 | Hemoptysis (HP:0002105) | 2.25016850 |
| 80 | Abnormality of the prostate (HP:0008775) | 2.24516561 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 2.22453360 |
| 82 | Anorexia (HP:0002039) | 2.21954200 |
| 83 | Autoimmune hemolytic anemia (HP:0001890) | 2.20721729 |
| 84 | Increased IgE level (HP:0003212) | 2.20593181 |
| 85 | Arterial thrombosis (HP:0004420) | 2.20523178 |
| 86 | Basal cell carcinoma (HP:0002671) | 2.19381384 |
| 87 | Viral hepatitis (HP:0006562) | 2.16127834 |
| 88 | Episodic fever (HP:0001954) | 2.14840665 |
| 89 | Purpura (HP:0000979) | 2.14550194 |
| 90 | Emphysema (HP:0002097) | 2.13173085 |
| 91 | Osteomyelitis (HP:0002754) | 2.13117872 |
| 92 | Chest pain (HP:0100749) | 2.11695159 |
| 93 | Gangrene (HP:0100758) | 2.09341943 |
| 94 | Hypochromic anemia (HP:0001931) | 2.08815734 |
| 95 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.07792835 |
| 96 | Reticulocytopenia (HP:0001896) | 2.07342286 |
| 97 | Sepsis (HP:0100806) | 2.06443889 |
| 98 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.05708507 |
| 99 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.05708507 |
| 100 | Abnormality of glycolipid metabolism (HP:0010969) | 2.05708507 |
| 101 | Abnormality of macrophages (HP:0004311) | 2.04793205 |
| 102 | Amaurosis fugax (HP:0100576) | 2.04504040 |
| 103 | Hypochromic microcytic anemia (HP:0004840) | 2.04262099 |
| 104 | Gingival bleeding (HP:0000225) | 2.04182834 |
| 105 | Hypergammaglobulinemia (HP:0010702) | 2.03085399 |
| 106 | Interstitial pulmonary disease (HP:0006530) | 2.02698118 |
| 107 | Abnormal platelet function (HP:0011869) | 2.02243476 |
| 108 | Impaired platelet aggregation (HP:0003540) | 2.02243476 |
| 109 | Joint swelling (HP:0001386) | 2.01681694 |
| 110 | Poikiloderma (HP:0001029) | 2.00805364 |
| 111 | Microcytic anemia (HP:0001935) | 2.00634573 |
| 112 | Keratoconjunctivitis (HP:0001096) | 1.99690740 |
| 113 | Premature loss of primary teeth (HP:0006323) | 1.99618089 |
| 114 | Glomerulopathy (HP:0100820) | 1.99547628 |
| 115 | Increased cerebral lipofuscin (HP:0011813) | 1.98926077 |
| 116 | Recurrent otitis media (HP:0000403) | 1.98448554 |
| 117 | Hepatosplenomegaly (HP:0001433) | 1.96741691 |
| 118 | Skin ulcer (HP:0200042) | 1.95520048 |
| 119 | Recurrent lower respiratory tract infections (HP:0002783) | 1.94414170 |
| 120 | Acute hepatic failure (HP:0006554) | 1.94333191 |
| 121 | Periodontitis (HP:0000704) | 1.93781123 |
| 122 | Arthralgia (HP:0002829) | 1.93152995 |
| 123 | Skin rash (HP:0000988) | 1.91958109 |
| 124 | Restrictive lung disease (HP:0002091) | 1.90358602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.50758108 |
| 2 | TXK | 3.49288514 |
| 3 | GRK6 | 2.70934724 |
| 4 | ZAP70 | 2.68591175 |
| 5 | PRPF4B | 2.66480857 |
| 6 | STK10 | 2.54213715 |
| 7 | KIT | 2.45917804 |
| 8 | EEF2K | 2.43007705 |
| 9 | JAK3 | 2.41553960 |
| 10 | TGFBR2 | 2.34756318 |
| 11 | BTK | 2.26893227 |
| 12 | ITK | 2.20632072 |
| 13 | SYK | 2.08603621 |
| 14 | TYK2 | 2.08213030 |
| 15 | CSF1R | 2.05660796 |
| 16 | TEC | 1.98678004 |
| 17 | BLK | 1.94360807 |
| 18 | IKBKE | 1.77746209 |
| 19 | NME2 | 1.74158184 |
| 20 | MAP3K10 | 1.72532539 |
| 21 | IRAK4 | 1.67871934 |
| 22 | TBK1 | 1.63774987 |
| 23 | MAP2K3 | 1.61371962 |
| 24 | LCK | 1.60985876 |
| 25 | FLT3 | 1.58385772 |
| 26 | PKN2 | 1.51758917 |
| 27 | ERN1 | 1.45585916 |
| 28 | MAP3K11 | 1.41626923 |
| 29 | CSK | 1.39145751 |
| 30 | LRRK2 | 1.38504508 |
| 31 | JAK1 | 1.35882293 |
| 32 | HCK | 1.34909407 |
| 33 | NLK | 1.31125853 |
| 34 | KDR | 1.30641785 |
| 35 | FGFR4 | 1.29937156 |
| 36 | FGR | 1.26305440 |
| 37 | FES | 1.24070246 |
| 38 | CLK1 | 1.21174445 |
| 39 | MAP3K14 | 1.19453188 |
| 40 | LYN | 1.17873198 |
| 41 | IKBKB | 1.15472454 |
| 42 | FGFR3 | 1.12629622 |
| 43 | PIM1 | 1.11989229 |
| 44 | TESK2 | 1.06092454 |
| 45 | BMPR2 | 1.04577407 |
| 46 | MAP3K12 | 1.01298856 |
| 47 | TAOK1 | 1.00861587 |
| 48 | CDK12 | 1.00375034 |
| 49 | MAP3K1 | 0.99308399 |
| 50 | MAP3K3 | 0.97829089 |
| 51 | SMG1 | 0.94991336 |
| 52 | SIK2 | 0.92712824 |
| 53 | RPS6KB2 | 0.91184016 |
| 54 | TGFBR1 | 0.85874188 |
| 55 | MST4 | 0.85339553 |
| 56 | NEK9 | 0.85139075 |
| 57 | MARK3 | 0.81478638 |
| 58 | PRKCQ | 0.80955203 |
| 59 | ADRBK2 | 0.78327931 |
| 60 | CDC7 | 0.77204249 |
| 61 | TNK2 | 0.76421954 |
| 62 | HIPK2 | 0.75128110 |
| 63 | RIPK4 | 0.74860713 |
| 64 | KSR2 | 0.74292389 |
| 65 | MAP3K13 | 0.74263028 |
| 66 | CDK4 | 0.74173882 |
| 67 | RPS6KA4 | 0.73939426 |
| 68 | PASK | 0.68960520 |
| 69 | SIK3 | 0.68111823 |
| 70 | STK4 | 0.67960978 |
| 71 | MATK | 0.66874029 |
| 72 | TAOK2 | 0.66594788 |
| 73 | NEK2 | 0.66274812 |
| 74 | TRIB3 | 0.65798689 |
| 75 | CHUK | 0.64356093 |
| 76 | MAP2K6 | 0.62334644 |
| 77 | JAK2 | 0.61371272 |
| 78 | PRKCH | 0.58089020 |
| 79 | CDC42BPA | 0.57938414 |
| 80 | PRKD2 | 0.57555393 |
| 81 | MAP2K2 | 0.57219249 |
| 82 | ILK | 0.56494544 |
| 83 | PIM2 | 0.56192699 |
| 84 | MAP3K7 | 0.55920729 |
| 85 | CAMKK1 | 0.53916968 |
| 86 | EIF2AK3 | 0.53612040 |
| 87 | YES1 | 0.52780683 |
| 88 | MAPK4 | 0.50232856 |
| 89 | CDK19 | 0.49531779 |
| 90 | TAOK3 | 0.48888313 |
| 91 | TSSK6 | 0.48836178 |
| 92 | PDPK1 | 0.48825841 |
| 93 | NUAK1 | 0.48798134 |
| 94 | ATR | 0.48216790 |
| 95 | EPHB1 | 0.46750167 |
| 96 | ACVR1B | 0.46234060 |
| 97 | MAPK11 | 0.45800303 |
| 98 | CAMKK2 | 0.44493680 |
| 99 | IRAK1 | 0.43766770 |
| 100 | RPS6KL1 | 0.43091128 |
| 101 | RPS6KC1 | 0.43091128 |
| 102 | RAF1 | 0.41207953 |
| 103 | PTK6 | 0.40923547 |
| 104 | GRK7 | 0.40736003 |
| 105 | ALK | 0.40594505 |
| 106 | IRAK3 | 0.40136950 |
| 107 | CDK9 | 0.40042334 |
| 108 | PDK1 | 0.35236886 |
| 109 | MAPK7 | 0.34723579 |
| 110 | PIK3CG | 0.34088048 |
| 111 | MAPK12 | 0.33912126 |
| 112 | MAP3K8 | 0.33130634 |
| 113 | STK16 | 0.32879286 |
| 114 | BCKDK | 0.32559040 |
| 115 | MARK2 | 0.32258956 |
| 116 | CCNB1 | 0.31600515 |
| 117 | MAP3K5 | 0.31291882 |
| 118 | CDK6 | 0.31156488 |
| 119 | IRAK2 | 0.30570376 |
| 120 | VRK1 | 0.29717793 |
| 121 | PAK4 | 0.29632531 |
| 122 | MAPKAPK2 | 0.29275329 |
| 123 | PRKCD | 0.29227822 |
| 124 | FYN | 0.28837606 |
| 125 | DYRK3 | 0.28703334 |
| 126 | CDK7 | 0.28493776 |
| 127 | RPS6KA6 | 0.27962842 |
| 128 | ABL1 | 0.24020959 |
| 129 | EPHA3 | 0.23664656 |
| 130 | DYRK1B | 0.23653322 |
| 131 | MAPK3 | 0.22470421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.21726367 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.66514906 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.65564067 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.63313959 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.58686356 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.49785504 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.46232371 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.44447693 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 2.33875065 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.30956583 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.28763280 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.21520899 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.14535687 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.98603050 |
| 15 | Mismatch repair_Homo sapiens_hsa03430 | 1.93426808 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.85819359 |
| 17 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.85135285 |
| 18 | Base excision repair_Homo sapiens_hsa03410 | 1.71204945 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67035755 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.64480729 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.62433100 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.62248759 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55323784 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.55291941 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.52197919 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.36371332 |
| 27 | Spliceosome_Homo sapiens_hsa03040 | 1.30701683 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.29122849 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.28993802 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27355318 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27246363 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22902540 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19844615 |
| 34 | Homologous recombination_Homo sapiens_hsa03440 | 1.18317367 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17829685 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.14311474 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.13694948 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11660184 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10993008 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.10301986 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.09747560 |
| 42 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.09001202 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07863446 |
| 44 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.03529107 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.03036049 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.02968336 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01564170 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 0.99171133 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99083386 |
| 50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.96075050 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 0.94818625 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 0.92696136 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92513161 |
| 54 | Tuberculosis_Homo sapiens_hsa05152 | 0.91503523 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89108558 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88040062 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84349634 |
| 58 | Colorectal cancer_Homo sapiens_hsa05210 | 0.84308710 |
| 59 | Cell cycle_Homo sapiens_hsa04110 | 0.82950922 |
| 60 | RNA polymerase_Homo sapiens_hsa03020 | 0.82502832 |
| 61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82320024 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.80627773 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80532653 |
| 64 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.80436394 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.79565613 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78900590 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.77971197 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.76463976 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74643855 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73533054 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73211415 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72695876 |
| 73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.67594932 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66386211 |
| 75 | RNA transport_Homo sapiens_hsa03013 | 0.64969214 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63685553 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63318692 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.62404247 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.60704979 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57623734 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56619783 |
| 82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52092045 |
| 83 | Proteasome_Homo sapiens_hsa03050 | 0.50788655 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49998266 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47826090 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47408557 |
| 87 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.45815601 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42640221 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42611383 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39586300 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39391444 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38759910 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38438255 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38303975 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38194573 |
| 96 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.38083399 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36761814 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36416318 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36280080 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35643923 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35091034 |
| 102 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.33560484 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.31706523 |
| 104 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31569217 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30851622 |
| 106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29803167 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29769511 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29466629 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29197249 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.28742521 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28448843 |
| 112 | Basal transcription factors_Homo sapiens_hsa03022 | 0.28025142 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27908728 |
| 114 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27310040 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27278888 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26854501 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26556129 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.26169522 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26163255 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25785500 |
| 121 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25780171 |
| 122 | Prostate cancer_Homo sapiens_hsa05215 | 0.25156658 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23944906 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22849405 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21998184 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15261017 |
| 127 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.15032625 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.14192932 |
| 129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.14066768 |

